Beranda › Limfoma Non-Hodgkin › Colorado › Denver
Uji klinis Limfoma Non-Hodgkin di Denver, CO
14 studi untuk Limfoma Non-Hodgkin mencari peserta di lokasi sekitar Denver (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Menerima pesertaFase 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Menerima pesertaFase 1/2
- Colorado Blood Cancer Institute ( Site 7000), Denver
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
- Colorado Blood Cancer Institute, Denver
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Menerima pesertaFase 1
- Colorado Blood Cancer Institute, Denver
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Menerima pesertaFase 1
- Colorado Blood Cancer Institute (Sarah Cannon), Denver
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Menerima pesertaFase 1/2
- Colorado Blood Cancer Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Menerima pesertaFase 1/2
- Colorado Blood Cancer Institute, Denver
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Menerima pesertaFase 3
- Colorado Blood Cancer Institute, Denver
DALY II USA/ MB-CART2019.1 for DLBCL
Menerima pesertaFase 2
- Colorado Blood Cancer Institute, Denver
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
Menerima pesertaFase 1
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- dan 1 lainnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Menerima pesertaFase 1
- Colorado Blood Cancer Institute, Denver
Uji klinis Limfoma Non-Hodgkin di kota lain
- New York City, NY31 studi
- Houston, TX31 studi
- Boston, MA26 studi
- Nashville, TN21 studi
- Philadelphia, PA20 studi
- Baldwin Park, CA19 studi
- Washington, DC18 studi
- Atlanta, GA18 studi
- Milwaukee, WI18 studi
- Chicago, IL18 studi
- Columbus, OH18 studi
- Dallas, TX17 studi
Studi lain di Denver
- Kanker Metastatik29 studi
- Kanker Payudara29 studi
- Kanker Paru Non-Sel Kecil27 studi
- Mieloma Multipel27 studi
- Kanker Kolorektal23 studi
- Melanoma19 studi
- Kanker Prostat19 studi
- Kanker (semua jenis)18 studi
- Kanker Ovarium16 studi
- Kanker Paru16 studi
- Kanker Endometrium15 studi
- Kanker Pankreas13 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.